Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06149338Not ApplicableCompleted

The Rate of Successful Intubation and the Required Time for Intubation, Using Vie Scope and Macintosh Laryngoscope Will be Compared, in Order to Evaluate the Efficacy of Vie Scope in Comparison With Macintosh in Expected Easy Airways.

Role: lead

NCT03477955Not ApplicableCompleted

PEEK Versus Silicon Interspinous Spacer for Reduction of Supradjacent Segment Degeneration

Role: collaborator

NCT03472131Not ApplicableCompleted

Unilateral Posterolateral Approach for Spondylodiskitis

Role: collaborator

NCT03431519Completed

Percutaneous Injection Plus Short Segment Pedicle Screw Fixation for Traumatic A2 and A3 AO-type Fractures in Adults

Role: collaborator

NCT01400711Not ApplicableCompleted

Enhanced Recovery After Surgery in Major Intrabdominal Procedures.

Role: lead

All 5 trials loaded